VCIM
VRCA icon

Velan Capital Investment Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Velan Capital Investment Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Hold
471,559
– – 1.76% 15
2026
Q1 		$2.49M Hold
471,559
– – 1.56% 18
2025
Q4 		$3.92M Buy
+471,559
New +$2.61M 2.27% 13

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Velan Capital Investment Management's VRCA Position: Q2 2026 in Review

Velan Capital Investment Management held its Verrica Pharmaceuticals (VRCA) position steady in Q2 2026 at 471,559 shares worth $2.89M. The position accounts for 1.76% of the portfolio, ranked #15.

Velan Capital Investment Management first reported a position in VRCA in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.92M in Q4 2025. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Velan Capital Investment Management held 471,559 shares of Verrica Pharmaceuticals worth $2.89M as of Q2 2026.
  • Velan Capital Investment Management left its Verrica Pharmaceuticals share count unchanged in Q2 2026.
  • Verrica Pharmaceuticals made up 1.76% of Velan Capital Investment Management's portfolio in Q2 2026, its #15 holding.
  • Velan Capital Investment Management first reported a position in Verrica Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Velan Capital Investment Management's Verrica Pharmaceuticals position peaked at $3.92M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.